Down 40%, This Growth Stock Could Be Set for a Recovery in 2026
Oracle is transforming from a tech stalwart to a major player in infrastructure and services for high-performance computing.
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
| Insider | Role | Date | Type | Value |
|---|---|---|---|---|
| KRONICK SUSAN D | Director | Aug 17 '26 | Sale | 305796.0 |
| SUSAN KRONICK | Director | Aug 17 '26 | Proposed Sale | 307666.0 |
| Bottarini Joan | See Remarks | Aug 03 '26 | Sale | 310925.0 |
| JOAN BOTTARINI | Officer | Aug 03 '26 | Proposed Sale | 317660.0 |
| HOPLAMAZIAN MARK SAMUEL | See Remarks | Jun 22 '26 | Sale | 16714337.0 |
| HOPLAMAZIAN MARK SAMUEL | See Remarks | Jun 18 '26 | Sale | 7157481.0 |
| MARK HOPLAMAZIAN REVOCABLE … | Officer | Jun 22 '26 | Proposed Sale | 16714112.0 |
| MARK HOPLAMAZIAN REVOCABLE … | Officer | Jun 18 '26 | Proposed Sale | 7157525.0 |
| PAUL BALLEW | Former Director | Jun 17 '26 | Proposed Sale | 1145956.0 |
| Udell David | See Remarks | Jun 02 '26 | Option Exercise | 152685.0 |
Source: FinViz — Data may be delayed
AI-curated news influencing H price, sentiment, and trend
Oracle is transforming from a tech stalwart to a major player in infrastructure and services for high-performance computing.
Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab.
Russell 2000 Lags S&P 500 as Small Caps Underperform in 2025
An impressive historical gain hasn't prevented this dominant business from seeing its shares soar 64% in 2025.
All of these stocks have excellent chances in 2026 and beyond.
MarketWatch asked the leading LLMs for their top stock picks — but the answers suggest AI may be following the …
Multi-Provider AI Analysis